Lymphoma, T-Cell, Cutaneous
"Lymphoma, T-Cell, Cutaneous" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A group of lymphomas exhibiting clonal expansion of malignant T-lymphocytes arrested at varying stages of differentiation as well as malignant infiltration of the skin. MYCOSIS FUNGOIDES; SEZARY SYNDROME; LYMPHOMATOID PAPULOSIS; and PRIMARY CUTANEOUS ANAPLASTIC LARGE CELL LYMPHOMA are the best characterized of these disorders.
Descriptor ID |
D016410
|
MeSH Number(s) |
C04.557.386.480.750.800 C15.604.515.569.480.750.800 C20.683.515.761.480.750.800
|
Concept/Terms |
Lymphoma, T-Cell, Cutaneous- Lymphoma, T-Cell, Cutaneous
- T-Cell Lymphoma, Cutaneous
- T Cell Lymphoma, Cutaneous
- Cutaneous T-Cell Lymphoma
- Cutaneous T Cell Lymphoma
- Cutaneous T-Cell Lymphomas
- Lymphoma, Cutaneous T-Cell
- Lymphomas, Cutaneous T-Cell
- T-Cell Lymphomas, Cutaneous
- Lymphoma, T Cell, Cutaneous
|
Below are MeSH descriptors whose meaning is more general than "Lymphoma, T-Cell, Cutaneous".
- Diseases [C]
- Neoplasms [C04]
- Neoplasms by Histologic Type [C04.557]
- Lymphoma [C04.557.386]
- Lymphoma, Non-Hodgkin [C04.557.386.480]
- Lymphoma, T-Cell [C04.557.386.480.750]
- Lymphoma, T-Cell, Cutaneous [C04.557.386.480.750.800]
- Hemic and Lymphatic Diseases [C15]
- Lymphatic Diseases [C15.604]
- Lymphoproliferative Disorders [C15.604.515]
- Lymphoma [C15.604.515.569]
- Lymphoma, Non-Hodgkin [C15.604.515.569.480]
- Lymphoma, T-Cell [C15.604.515.569.480.750]
- Lymphoma, T-Cell, Cutaneous [C15.604.515.569.480.750.800]
- Immune System Diseases [C20]
- Immunoproliferative Disorders [C20.683]
- Lymphoproliferative Disorders [C20.683.515]
- Lymphoma [C20.683.515.761]
- Lymphoma, Non-Hodgkin [C20.683.515.761.480]
- Lymphoma, T-Cell [C20.683.515.761.480.750]
- Lymphoma, T-Cell, Cutaneous [C20.683.515.761.480.750.800]
Below are MeSH descriptors whose meaning is more specific than "Lymphoma, T-Cell, Cutaneous".
This graph shows the total number of publications written about "Lymphoma, T-Cell, Cutaneous" by people in this website by year, and whether "Lymphoma, T-Cell, Cutaneous" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 2 | 0 | 2 |
1996 | 4 | 0 | 4 |
1997 | 5 | 0 | 5 |
1998 | 3 | 0 | 3 |
1999 | 3 | 0 | 3 |
2000 | 4 | 0 | 4 |
2001 | 7 | 0 | 7 |
2002 | 4 | 1 | 5 |
2003 | 7 | 0 | 7 |
2004 | 3 | 0 | 3 |
2005 | 3 | 1 | 4 |
2006 | 6 | 1 | 7 |
2007 | 12 | 1 | 13 |
2008 | 7 | 1 | 8 |
2009 | 2 | 0 | 2 |
2010 | 8 | 2 | 10 |
2011 | 4 | 1 | 5 |
2012 | 10 | 0 | 10 |
2013 | 4 | 0 | 4 |
2014 | 8 | 1 | 9 |
2015 | 11 | 1 | 12 |
2016 | 4 | 1 | 5 |
2017 | 14 | 0 | 14 |
2018 | 5 | 0 | 5 |
2019 | 5 | 1 | 6 |
2020 | 6 | 1 | 7 |
2021 | 6 | 0 | 6 |
2022 | 6 | 0 | 6 |
2023 | 4 | 0 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Lymphoma, T-Cell, Cutaneous" by people in Profiles.
-
Real-World Treatment Patterns and Clinical Outcomes With Brentuximab Vedotin or Other Standard Therapies in Patients With Previously Treated Cutaneous T-Cell Lymphoma in the United States. Clin Lymphoma Myeloma Leuk. 2024 02; 24(2):e21-e32.e4.
-
New JAK3-INSL3 Fusion Transcript-An Oncogenic Event in Cutaneous T-Cell Lymphoma. Cells. 2023 09 29; 12(19).
-
Complete Response to tenalisib and romidepsin with long-term maintenance using tenalisib monotherapy in a patient with relapsed and refractory s?zary syndrome. Invest New Drugs. 2023 04; 41(2):350-355.
-
Cutaneous T-Cell Lymphoma: Current and Emerging Therapies. Oncology (Williston Park). 2023 02 24; 37(2):55-62.
-
Efficacy and Safety of Topical Hypericin Photodynamic Therapy for Early-Stage Cutaneous T-Cell Lymphoma (Mycosis Fungoides): The FLASH Phase 3 Randomized Clinical Trial. JAMA Dermatol. 2022 09 01; 158(9):1031-1039.
-
Primary cutaneous lymphoma: recommendations for clinical trial design and staging update from the ISCL, USCLC, and EORTC. Blood. 2022 08 04; 140(5):419-437.
-
Expression pattern and diagnostic utility of BCL11B in mature T- and NK-cell neoplasms. Pathology. 2022 Dec; 54(7):893-899.
-
Long-term disease control and safety with the anti-CCR4 antibody mogamulizumab: Post-hoc analyses from the MAVORIC trial of patients with previously treated cutaneous T-cell lymphoma. Dermatol Ther. 2022 08; 35(8):e15634.
-
Genomic and Single-Cell Landscape Reveals Novel Drivers and Therapeutic Vulnerabilities of Transformed Cutaneous T-cell Lymphoma. Cancer Discov. 2022 05 02; 12(5):1294-1313.
-
CD4/CD8 double-negative mycosis fungoides with large cell transformation and involvement of the lungs and leptomeninges. Dermatol Online J. 2022 Mar 15; 28(2).